{
  "step1Contents": {
    "navTitle": "Thyroid Case Study",
    "navDescription": "Description about how there are two regulatory questions for the thyroid case study. The user can either choose one of the two questions to explore or scroll down to read the overview of the case study.",
    "questions": [
      {
        "label": "Question 1: Compound Information",
        "description": "What information about a compound do we need to advise women in their early pregnancy to decide whether the compound can be used?",
        "value": "Q1"
      },
      {
        "label": "Question 2: Fetal Brain Development",
        "description": "Does compound Z influence the thyroid-mediated brain development in the fetus resulting in cognitive impairment in children?",
        "value": "Q2"
      }
    ],
    "content": "<h2>Case Study Overview</h2><p>This will go over all the information that is relevant to the thyroid case study as a whole. It will include a description of the case study, the regulatory questions, and how the case study is structured. It will also contain additonal details such as the people who worked on the case study, the tools used, and any other relevant information. This information will be structured to emphasize relevant details and provide a clear overview of the case study by using different layouts instead of plain text.</p>"
  },
  "step2Contents": {
    "Q1": {
      "navTitle": "Process Flow Steps (Q1)",
      "navDescription": "This regulatory question has been researched using the following process flow steps. The user will be able to click on one of the buttons below to find out more about the step or scroll down to learn more about this specific regulatory question. Not every regulatory question will use each step from the general process flow, only the ones used will be presented here for now. I might update it to show all.",
      "steps": [
        {
          "label": "Chemical Characteristics",
          "value": "Chemical Characteristics"
        },
        { "label": "External Exposure", "value": "External Exposure" },
        { "label": "Kinetics", "value": "Kinetics" },
        { "label": "AOP", "value": "AOP" },
        { "label": "Adverse Outcome", "value": "Adverse Outcome" }
      ],
      "content": "<h2>Thyroid-related Regulatory Question 1</h2><p>This is where the content for regulatory question 1 will go. It will include a description of the regulatory question, the tools used, and any other relevant information. This information will be structured to emphasize relevant details and provide a clear overview of the regulatory question by using different layouts instead of plain text.</p>"
    },
    "Q2": {
      "navTitle": "Process Flow Steps (Q2)",
      "navDescription": "This regulatory question has been researched using the following process flow steps. The user will be able to click on one of the buttons below to find out more about the step or scroll down to learn more about this specific regulatory question. Not every regulatory question will use each step from the general process flow, only the ones used will be presented here for now. I might update it to show all.",
      "steps": [
        {
          "label": "Chemical Characteristics",
          "value": "Chemical Characteristics"
        },
        { "label": "External Exposure", "value": "External Exposure" },
        { "label": "Kinetics", "value": "Kinetics" },
        { "label": "AOP", "value": "AOP" },
        { "label": "Adverse Outcome", "value": "Adverse Outcome" }
      ],
      "content": "<h2>Thyroid-related Regulatory Question 2</h2><p>This is where the content for regulatory question 2 will go. It will include a description of the regulatory question, the tools used, and any other relevant information. This information will be structured to emphasize relevant details and provide a clear overview of the regulatory question by using different layouts instead of plain text.</p>"
    }
  },
  "step3Contents": {
    "Q1": {
      "Chemical Characteristics": {
        "navTitle": "Chemical Characteristics - Tools and Workflow (Q1)",
        "navDescription": "For regulatory question 1, the chemical characteristics of the compound are analyzed to determine its properties relevant to use in early pregnancy. Tools such as chemical structure viewers and property calculators were used.",
        "tools": [
          {
            "label": "Structure Viewer",
            "description": "Visualizes the molecular structure of the compound."
          },
          {
            "label": "Property Calculator",
            "description": "Calculates key chemical properties like logP, solubility, and molecular weight."
          }
        ],
        "content": "<h2>Chemical Characteristics Workflow for Regulatory Question 1</h2><p>This section describes how chemical characteristics were assessed for Q1, including the tools used and the rationale for their selection. The results inform the safety assessment for pregnant women.</p>"
      },
      "External Exposure": {
        "navTitle": "External Exposure - Tools and Workflow (Q1)",
        "navDescription": "For regulatory question 1, external exposure estimation tools were used to model how much of the compound women might be exposed to during early pregnancy.",
        "tools": [
          {
            "label": "Exposure Model",
            "description": "Estimates daily intake based on use scenarios."
          }
        ],
        "content": "<h2>External Exposure Workflow for Regulatory Question 1</h2><p>This section explains the approach to estimating external exposure, including assumptions and data sources. The exposure estimates are used in the risk assessment process.</p>"
      },
      "Kinetics": {
        "navTitle": "Kinetics - Tools and Workflow (Q1)",
        "navDescription": "The kinetics aspect of regulatory question 1 of the Thyroid case study has been researched using the following tools. Select one to learn more or scroll down to read more about the kinetics research process.",
        "tools": [
          {
            "label": "PBPK Model",
            "description": "Simulates absorption, distribution, metabolism, and excretion in pregnant women."
          }
        ],
        "content": "<h2>Kinetics Workflow for Regulatory Question 1</h2><p>This is where the process of the kinetics research will be described for regulatory question 1. It will include the tools used, how they have been used, any assumptions made, why choices have been made, etc. It will also link to any other relevant pages or resources that are relevant to the kinetics research for regulatory question 1.</p>"
      },
      "AOP": {
        "navTitle": "AOP - Tools and Workflow (Q1)",
        "navDescription": "For regulatory question 1, Adverse Outcome Pathways (AOPs) were mapped to understand the biological mechanisms affected by the compound.",
        "tools": [
          {
            "label": "AOP Mapper",
            "description": "Visualizes the pathway from molecular interaction to adverse outcome."
          }
        ],
        "content": "<h2>AOP Workflow for Regulatory Question 1</h2><p>This section describes the AOPs relevant to Q1 and how they inform the risk assessment for pregnant women.</p>"
      },
      "Adverse Outcome": {
        "navTitle": "Adverse Outcome - Tools and Workflow (Q1)",
        "navDescription": "For regulatory question 1, the potential adverse outcomes for the mother and fetus were evaluated using literature review and expert input.",
        "tools": [
          {
            "label": "Outcome Database",
            "description": "Summarizes known adverse outcomes associated with the compound."
          }
        ],
        "content": "<h2>Adverse Outcome Workflow for Regulatory Question 1</h2><p>This section summarizes the adverse outcomes considered for Q1 and how they were integrated into the overall assessment.</p>"
      }
    },
    "Q2": {
      "Chemical Characteristics": {
        "navTitle": "Chemical Characteristics - Tools and Workflow (Q2)",
        "navDescription": "For regulatory question 2, the chemical characteristics of compound Z were analyzed to assess its potential to disrupt thyroid-mediated brain development.",
        "tools": [
          {
            "label": "Structure Viewer",
            "description": "Visualizes the molecular structure of compound Z."
          }
        ],
        "content": "<h2>Chemical Characteristics Workflow for Regulatory Question 2</h2><p>This section describes the chemical analysis for Q2 and its relevance to fetal brain development.</p>"
      },
      "External Exposure": {
        "navTitle": "External Exposure - Tools and Workflow (Q2)",
        "navDescription": "For regulatory question 2, external exposure models were used to estimate fetal exposure to compound Z.",
        "tools": [
          {
            "label": "Exposure Model",
            "description": "Estimates fetal exposure based on maternal intake and placental transfer."
          }
        ],
        "content": "<h2>External Exposure Workflow for Regulatory Question 2</h2><p>This section explains the approach to estimating fetal exposure for Q2, including key assumptions and data sources.</p>"
      },
      "Kinetics": {
        "navTitle": "Kinetics - Tools and Workflow (Q2)",
        "navDescription": "The kinetics aspect of regulatory question 2 of the Thyroid case study has been researched using the following tools. Select one to learn more or scroll down to read more about the kinetics research process.",
        "tools": [
          {
            "label": "PBPK Model",
            "description": "Simulates maternal-fetal transfer and metabolism of compound Z."
          }
        ],
        "content": "<h2>Kinetics Workflow for Regulatory Question 2</h2><p>This is where the process of the kinetics research will be described for regulatory question 2. It will include the tools used, how they have been used, any assumptions made, why choices have been made, etc. It will also link to any other relevant pages or resources that are relevant to the kinetics research for regulatory question 2.</p>"
      },
      "AOP": {
        "navTitle": "AOP - Tools and Workflow (Q2)",
        "navDescription": "For regulatory question 2, AOPs were mapped to understand how compound Z may affect thyroid hormone signaling and brain development.",
        "tools": [
          {
            "label": "AOP Mapper",
            "description": "Visualizes the pathway from thyroid disruption to cognitive impairment."
          }
        ],
        "content": "<h2>AOP Workflow for Regulatory Question 2</h2><p>This section describes the AOPs relevant to Q2 and their implications for fetal brain development.</p>"
      },
      "Adverse Outcome": {
        "navTitle": "Adverse Outcome - Tools and Workflow (Q2)",
        "navDescription": "For regulatory question 2, the potential adverse outcomes for the fetus were evaluated, focusing on cognitive development.",
        "tools": [
          {
            "label": "Outcome Database",
            "description": "Summarizes known neurodevelopmental outcomes associated with thyroid disruption."
          }
        ],
        "content": "<h2>Adverse Outcome Workflow for Regulatory Question 2</h2><p>This section summarizes the adverse outcomes considered for Q2 and their relevance to the risk assessment.</p>"
      }
    }
  }
}
